Article (Scientific journals)
Harmonising clinical trials within the Gynecologic Cancer InterGroup: Consensus and unmet needs from the Fifth Ovarian Cancer Consensus Conference
Bookman, M. A.; Okamoto, A.; Stuart, G. et al.
2017In Annals of Oncology, 28, p. 30-viii35
Peer Reviewed verified by ORBi
 

Files


Full Text
mdx449.pdf
Publisher postprint (131.71 kB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Clinical trial; Consensus statement; Ovarian cancer; Article; Japan; Female; Humans; Needs Assessment; Ovarian Neoplasms; Randomized Controlled Trials as Topic
Abstract :
[en] The Gynecologic Cancer InterGroup (GCIG) Fifth Ovarian Cancer Consensus Conference (OCCC) was held in Tokyo, Japan from 7 to 9 November 2015. It provided international consensus on 15 important questions in 4 topic areas, which were generated in accordance with the mission statement to establish 'International Consensus for Designing Better Clinical Trials'. The methodology for obtaining consensus was previously established and followed during the Fifth OCCC. All 29 clinical trial groups of GCIG participated in program development and deliberations. Draft consensus statements were discussed in topic groups as well as in a plenary forum. The final statements were then presented to all 29 member groups for voting and documentation of the level of consensus. Full consensus was obtained for 11 of the 15 statements with 28/29 groups agreeing to 3 statements, and 27/29 groups agreeing to 1 statement. The high acceptance rate of the statements among trial groups reflects the fact that we share common questions, and recognise important unmet needs that will guide future research in ovarian cancer. © The Author 2017. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved.
Disciplines :
Oncology
Author, co-author :
Bookman, M. A.;  GOG, United States
Okamoto, A.;  JGOG, Japan
Stuart, G.;  CCTG, Canada
Yanaihara, N.;  JGOG, Japan
Aoki, D.;  JGOG, Japan
Bacon, M.;  GCIG, United States
Fujiwara, K.;  GOTIC, Japan
González-Martín, A.;  GEICO, Spain
Harter, P.;  AGO, Germany
Kim, J. W.;  KGOG, South Korea
Ledermann, J.;  MRC/NCRI, United Kingdom
Pujade-Lauraine, E.;  GINECO, France
Quinn, M.;  ANZGOG, Australia
Ochiai, K.;  JGOG, Japan
Zeimet, A.;  AGO-AU, Austria
Marth, C.;  AGO-AU, Austria
Dubois, Alain
Hilpert, F.;  AGO, Germany
Pfisterer, J.;  AGO, Germany
Reuss, A.;  AGO, Germany
Friedlander, M.;  ANZGOG, Australia
Wilson, M. K.;  ANZGOG, Australia
Kridelka, Frédéric ;  Université de Liège - ULiège > Département des sciences cliniques > Gynécologie-Obstétrique
Vergote, I.;  BGOG, Belgium
Berek, J.;  COGi, United States
Dorigo, O.;  COGi, United States
Karam, A.;  COGi, United States
Bekkers, R.;  DGOG, Netherlands
Westermann, A.;  DGOG, Netherlands
Gatsonis, C.;  ECOG-ACRIN, United States
Ng, C.;  ECOG-ACRIN, United States
Herráez, A. C.;  EORTC-GCG, United Kingdom
Ottevanger, N.;  EORTC-GCG, United Kingdom
Poveda, A.;  GEICO, Spain
Redondo, A.;  GEICO, Spain
Coleman, R.;  G-GOC, United States
Lu, K.;  G-GOC, United States
Gallardo-Rincón, D.;  GICOM, Mexico
Gomez-Garcia, E.;  GICOM, Mexico
Joly, F.;  GINECO, France
Leary, A.;  GINECO, France
Ray-Coquard, I.;  GINECO, France
Burger, R.;  GOG, United States
Moore, K. N.;  GOG, United States
Fujiwara, H.;  GOTIC, Japan
Hasegawa, K.;  GOTIC, Japan
Gleeson, N.;  ICORG, Ireland
Levy, T.;  ISGO, Israel
Rosengarten, O.;  ISGO, Israel
Katsumata, N.;  JGOG, Japan
Silverberg, S. G.;  JGOG, Japan
Sugiyama, T.;  JGOG, Japan
Chang, S.-J.;  KGOG, South Korea
Kim, B.-G.;  KGOG, South Korea
Nam, B.-H.;  KGOG, South Korea
Colombo, N.;  MaNGO, Italy
Ferrero, A.;  MaNGO, Italy
Lorusso, D.;  MITO, Italy
Scambia, G.;  MITO, Italy
Edmondson, R.;  MRC/NCRI, United Kingdom
McNeish, I.;  MRC/NCRI, United Kingdom
Kohn, E.;  National Cancer Institute, United States
Hirte, H.;  CCTG, Canada
McGee, J.;  CCTG, Canada
Provencher, D.;  CCTG, Canada
Sehouli, J.;  NOGGO, Germany
Wimberger, P.;  NOGGO, Germany
Maenpaa, J.;  NSGO, Scandinavia, United Kingdom
Mirza, Mansoor Raza
Oza, A.;  PMHC, Canada
Welch, S.;  PMHC, Canada
Gaffney, D.;  RTOG, United States
Small, W.;  RTOG, United States
Glasspool, R.;  SGCTG, United Kingdom
Gourley, C.;  SGCTG, United Kingdom
Millan, D.;  SGCTG, United Kingdom
Zang, R.;  SGOG, China
Zhu, J.;  SGOG, China
More authors (68 more) Less
Language :
English
Title :
Harmonising clinical trials within the Gynecologic Cancer InterGroup: Consensus and unmet needs from the Fifth Ovarian Cancer Consensus Conference
Publication date :
2017
Journal title :
Annals of Oncology
ISSN :
0923-7534
eISSN :
1569-8041
Publisher :
Oxford University Press
Volume :
28
Pages :
viii30-viii35
Peer reviewed :
Peer Reviewed verified by ORBi
Funders :
AstraZeneca [BE]
BMS - Bristol-Myers Squibb [BE]
Clovis Oncology [US-CO] [US-CO]
Eisai Co.
Roche [BE]
Pfizer [US-NY]
Pharma Mar
TESARO
Zeria Pharmaceutical
Available on ORBi :
since 13 December 2020

Statistics


Number of views
78 (4 by ULiège)
Number of downloads
67 (2 by ULiège)

Scopus citations®
 
35
Scopus citations®
without self-citations
20
OpenCitations
 
31

Bibliography


Similar publications



Contact ORBi